368 related articles for article (PubMed ID: 16706268)
1. Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment.
Rajkumar SV; Dispenzieri A; Kyle RA
Mayo Clin Proc; 2006 May; 81(5):693-703. PubMed ID: 16706268
[TBL] [Abstract][Full Text] [Related]
2. Neurologic aspects of plasma cell disorders.
Sobol U; Stiff P
Handb Clin Neurol; 2014; 120():1083-99. PubMed ID: 24365373
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular disorders associated with paraproteinemia.
Hoffman-Snyder C; Smith BE
Phys Med Rehabil Clin N Am; 2008 Feb; 19(1):61-79, vi. PubMed ID: 18194750
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Rajkumar SV; Lacy MQ; Kyle RA
Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell neoplasms and related entities-evolution in diagnosis and classification.
Fend F; Dogan A; Cook JR
Virchows Arch; 2023 Jan; 482(1):163-177. PubMed ID: 36414803
[TBL] [Abstract][Full Text] [Related]
6. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
Mayo MM; Johns GS
Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.
Tedeschi A; Conticello C; Rizzi R; Benevolo G; Laurenti L; Petrucci MT; Zaja F; Varettoni M
Hematol Oncol; 2019 Apr; 37(2):117-128. PubMed ID: 30192023
[TBL] [Abstract][Full Text] [Related]
8. Review of peripheral neuropathy in plasma cell disorders.
Silberman J; Lonial S
Hematol Oncol; 2008 Jun; 26(2):55-65. PubMed ID: 18324611
[TBL] [Abstract][Full Text] [Related]
9. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
International Myeloma Working Group
Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789
[TBL] [Abstract][Full Text] [Related]
10. Systemic manifestations of monoclonal gammopathy.
Decaux O; Laurat E; Perlat A; Cazalets C; Jego P; Grosbois B
Eur J Intern Med; 2009 Sep; 20(5):457-61. PubMed ID: 19712843
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of multiple myeloma and related disorders.
Kyle RA
Prog Hematol; 1986; 14():257-82. PubMed ID: 2418463
[No Abstract] [Full Text] [Related]
12. Diagnostic criteria of multiple myeloma.
Kyle RA
Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
[TBL] [Abstract][Full Text] [Related]
13. Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia.
Gnemmi V; Leleu X; Provot F; Moulonguet F; Buob D
Am J Kidney Dis; 2012 Sep; 60(3):487-91. PubMed ID: 22721930
[TBL] [Abstract][Full Text] [Related]
14. Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.
Graziani MS; Merlini G
Expert Rev Mol Diagn; 2014 Jan; 14(1):55-66. PubMed ID: 24308339
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal gammopathy and neuropathy.
Lozeron P; Adams D
Curr Opin Neurol; 2007 Oct; 20(5):536-41. PubMed ID: 17885441
[TBL] [Abstract][Full Text] [Related]
17. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
Kyle RA; Therneau TM; Rajkumar SV; Offord JR; Larson DR; Plevak MF; Melton LJ
N Engl J Med; 2002 Feb; 346(8):564-9. PubMed ID: 11856795
[TBL] [Abstract][Full Text] [Related]
18. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
[TBL] [Abstract][Full Text] [Related]
20. Clinical aspects of multiple myeloma and related disorders including amyloidosis.
Kyle RA
Pathol Biol (Paris); 1999 Feb; 47(2):148-57. PubMed ID: 10192881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
